Tandon Nina, Taubman Alanna, Cimetta Elisa, Saccenti Laetitia, Vunjak-Novakovic Gordana
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:6219-23. doi: 10.1109/EMBC.2013.6610974.
Cardiac tissue engineering aims to create functional tissue constructs that can reestablish the structure and function of injured myocardium. Although bioreactors have facilitated the engineering of cardiac patches of clinically relevant size in vitro, a major drawback remains the transportation of the engineered tissues from a production facility to a medical operation facility while maintaining tissue viability and preventing contamination. Furthermore, after implantation, most of the cells are endangered by hypoxic conditions that exist before vascular flow is established. We developed a portable device that provides the perfusion and electrical stimulation necessary to engineer cardiac tissue in vitro, and to transport it to the site where it will be implantated. The micropump-powered perfusion apparatus may additionally function as an extracorporeal active pumping system providing nutrients and oxygen supply to the graft post-implantation. Such a system, through perfusion of oxygenated media and bioactive molecules (e.g. growth factors), could transiently support the tissue construct until it connects to the host vasculature and heart muscle, after which it could be taken away or let biodegrade.
心脏组织工程旨在创建功能性组织构建体,以重建受损心肌的结构和功能。尽管生物反应器有助于在体外构建具有临床相关尺寸的心脏补片,但一个主要缺点仍然是如何将工程化组织从生产设施运输到医疗手术设施,同时保持组织活力并防止污染。此外,植入后,在建立血管血流之前,大多数细胞会受到缺氧条件的威胁。我们开发了一种便携式设备,该设备可提供在体外构建心脏组织并将其运输到植入部位所需的灌注和电刺激。由微型泵驱动的灌注装置还可以作为体外主动泵系统,在植入后为移植物提供营养和氧气供应。这样的系统通过灌注含氧培养基和生物活性分子(例如生长因子),可以暂时支持组织构建体,直到它与宿主血管和心肌连接,之后可以将其移除或使其生物降解。